Argos Therapeutics, Inc. ARGS
Set alert
0.27 -7 0.00 0.00%
At close · Jun 28
0.25 Day range 0.2849
0.1251 52-week range 3.89
- Open
- 0.265
- Prev close
- 0.2701
- Mkt cap
- 0
- Vol
- 758.98K
- Avg vol
- 2.63M
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.25
- High
- 0.2849
- Forward P/E
- -0.02
- Beta
- -0.49
- Short ratio
- 0.94
- Inst. own
- 1.84%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.144417
- 200-d avg
- 0.147355
- 1y target
- 0.75
Analyst view
Consensus: hold
Hold
Price target (mean) 0.75
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 2
- 2 months ago 2
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -11.60 | 0.0% | 50.00K | -52.4% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -4.20 | 0.0% | 50.00K | -28.6% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 200.00K | -89.5% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 500.00K | +150.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 22, 2017 | Needham | Downgrade | — | Hold |
| Mar 25, 2015 | Roth Capital | Initiated | — | Buy |
| Feb 24, 2015 | MLV & Co. | Initiated | — | Buy |
| Mar 3, 2014 | Stifel Nicolaus | Initiated | — | Buy |